Logo image of CTRE

CARETRUST REIT INC (CTRE) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CTRE - US14174T1079 - REIT

36.59 USD
+0.3 (+0.83%)
Last: 12/15/2025, 8:19:30 PM
36.59 USD
0 (0%)
After Hours: 12/15/2025, 8:19:30 PM
Fundamental Rating

7

Overall CTRE gets a fundamental rating of 7 out of 10. We evaluated CTRE against 128 industry peers in the Diversified REITs industry. CTRE scores excellent on profitability, but there are some minor concerns on its financial health. CTRE is growing strongly while it is still valued neutral. This is a good combination! These ratings could make CTRE a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CTRE had positive earnings in the past year.
CTRE had a positive operating cash flow in the past year.
Of the past 5 years CTRE 4 years were profitable.
CTRE had a positive operating cash flow in each of the past 5 years.
CTRE Yearly Net Income VS EBIT VS OCF VS FCFCTRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

CTRE has a better Return On Assets (5.12%) than 94.53% of its industry peers.
CTRE's Return On Equity of 6.53% is fine compared to the rest of the industry. CTRE outperforms 74.22% of its industry peers.
CTRE's Return On Invested Capital of 4.58% is amongst the best of the industry. CTRE outperforms 90.63% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CTRE is above the industry average of 3.05%.
Industry RankSector Rank
ROA 5.12%
ROE 6.53%
ROIC 4.58%
ROA(3y)1.9%
ROA(5y)3.08%
ROE(3y)2.37%
ROE(5y)4.75%
ROIC(3y)5.24%
ROIC(5y)5.34%
CTRE Yearly ROA, ROE, ROICCTRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

The Profit Margin of CTRE (60.84%) is better than 99.22% of its industry peers.
CTRE's Profit Margin has improved in the last couple of years.
CTRE has a better Operating Margin (66.50%) than 99.22% of its industry peers.
In the last couple of years the Operating Margin of CTRE has grown nicely.
CTRE's Gross Margin of 99.38% is amongst the best of the industry. CTRE outperforms 100.00% of its industry peers.
Industry RankSector Rank
OM 66.5%
PM (TTM) 60.84%
GM 99.38%
OM growth 3Y5.41%
OM growth 5Y3.45%
PM growth 3Y4.22%
PM growth 5Y8.32%
GM growth 3YN/A
GM growth 5YN/A
CTRE Yearly Profit, Operating, Gross MarginsCTRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CTRE is destroying value.
CTRE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CTRE has been increased compared to 5 years ago.
Compared to 1 year ago, CTRE has an improved debt to assets ratio.
CTRE Yearly Shares OutstandingCTRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CTRE Yearly Total Debt VS Total AssetsCTRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 4.69 indicates that CTRE is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 4.69, CTRE belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
CTRE has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CTRE (0.22) is better than 97.66% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 4.69
ROIC/WACC0.53
WACC8.58%
CTRE Yearly LT Debt VS Equity VS FCFCTRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

A Current Ratio of 4.05 indicates that CTRE has no problem at all paying its short term obligations.
CTRE's Current ratio of 4.05 is amongst the best of the industry. CTRE outperforms 92.19% of its industry peers.
CTRE has a Quick Ratio of 4.05. This indicates that CTRE is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CTRE (4.05) is better than 92.19% of its industry peers.
Industry RankSector Rank
Current Ratio 4.05
Quick Ratio 4.05
CTRE Yearly Current Assets VS Current LiabilitesCTRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

9

3. Growth

3.1 Past

CTRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 90.28%, which is quite impressive.
The Earnings Per Share has been growing by 11.30% on average over the past years. This is quite good.
Looking at the last year, CTRE shows a very strong growth in Revenue. The Revenue has grown by 59.24%.
The Revenue has been growing by 12.64% on average over the past years. This is quite good.
EPS 1Y (TTM)90.28%
EPS 3Y-1.19%
EPS 5Y11.3%
EPS Q2Q%66.67%
Revenue 1Y (TTM)59.24%
Revenue growth 3Y15.48%
Revenue growth 5Y12.64%
Sales Q2Q%71.16%

3.2 Future

The Earnings Per Share is expected to grow by 26.77% on average over the next years. This is a very strong growth
Based on estimates for the next years, CTRE will show a very strong growth in Revenue. The Revenue will grow by 27.93% on average per year.
EPS Next Y77.17%
EPS Next 2Y38.47%
EPS Next 3Y26.77%
EPS Next 5YN/A
Revenue Next Year45.48%
Revenue Next 2Y35.93%
Revenue Next 3Y27.93%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CTRE Yearly Revenue VS EstimatesCTRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CTRE Yearly EPS VS EstimatesCTRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 26.71 indicates a quite expensive valuation of CTRE.
Based on the Price/Earnings ratio, CTRE is valued a bit cheaper than 68.75% of the companies in the same industry.
CTRE is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.55, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 23.27, the valuation of CTRE can be described as rather expensive.
Based on the Price/Forward Earnings ratio, CTRE is valued cheaply inside the industry as 89.84% of the companies are valued more expensively.
CTRE is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.78, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 26.71
Fwd PE 23.27
CTRE Price Earnings VS Forward Price EarningsCTRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CTRE is valued more expensive than 87.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 22.61
CTRE Per share dataCTRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

CTRE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of CTRE may justify a higher PE ratio.
A more expensive valuation may be justified as CTRE's earnings are expected to grow with 26.77% in the coming years.
PEG (NY)0.35
PEG (5Y)2.36
EPS Next 2Y38.47%
EPS Next 3Y26.77%

5

5. Dividend

5.1 Amount

CTRE has a Yearly Dividend Yield of 3.73%.
CTRE's Dividend Yield is slightly below the industry average, which is at 6.20.
CTRE's Dividend Yield is rather good when compared to the S&P500 average which is at 1.87.
Industry RankSector Rank
Dividend Yield 3.73%

5.2 History

The dividend of CTRE has a limited annual growth rate of 4.05%.
CTRE has paid a dividend for at least 10 years, which is a reliable track record.
As CTRE did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)4.05%
Div Incr Years9
Div Non Decr Years9
CTRE Yearly Dividends per shareCTRE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

89.87% of the earnings are spent on dividend by CTRE. This is not a sustainable payout ratio.
The dividend of CTRE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP89.87%
EPS Next 2Y38.47%
EPS Next 3Y26.77%
CTRE Yearly Income VS Free CF VS DividendCTRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M
CTRE Dividend Payout.CTRE Dividend Payout, showing the Payout Ratio.CTRE Dividend Payout.PayoutRetained Earnings

CARETRUST REIT INC

NYSE:CTRE (12/15/2025, 8:19:30 PM)

After market: 36.59 0 (0%)

36.59

+0.3 (+0.83%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-10 2026-02-10/amc
Inst Owners102.36%
Inst Owner Change13.66%
Ins Owners0.34%
Ins Owner Change0%
Market Cap8.17B
Revenue(TTM)428.48M
Net Income(TTM)260.67M
Analysts83.75
Price Target40.19 (9.84%)
Short Float %4.63%
Short Ratio5.34
Dividend
Industry RankSector Rank
Dividend Yield 3.73%
Yearly Dividend1.09
Dividend Growth(5Y)4.05%
DP89.87%
Div Incr Years9
Div Non Decr Years9
Ex-Date09-30 2025-09-30 (0.335)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.91%
Min EPS beat(2)-4.24%
Max EPS beat(2)0.43%
EPS beat(4)2
Avg EPS beat(4)-2.07%
Min EPS beat(4)-6.76%
Max EPS beat(4)2.3%
EPS beat(8)2
Avg EPS beat(8)-16.79%
EPS beat(12)2
Avg EPS beat(12)-31.23%
EPS beat(16)3
Avg EPS beat(16)-31.08%
Revenue beat(2)2
Avg Revenue beat(2)16.61%
Min Revenue beat(2)3.69%
Max Revenue beat(2)29.53%
Revenue beat(4)2
Avg Revenue beat(4)1.76%
Min Revenue beat(4)-15.93%
Max Revenue beat(4)29.53%
Revenue beat(8)4
Avg Revenue beat(8)4.87%
Revenue beat(12)7
Avg Revenue beat(12)3.98%
Revenue beat(16)9
Avg Revenue beat(16)2.72%
PT rev (1m)4.23%
PT rev (3m)9.07%
EPS NQ rev (1m)-0.52%
EPS NQ rev (3m)1.33%
EPS NY rev (1m)-0.17%
EPS NY rev (3m)1.13%
Revenue NQ rev (1m)0.85%
Revenue NQ rev (3m)7.32%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.66%
Valuation
Industry RankSector Rank
PE 26.71
Fwd PE 23.27
P/S 19.07
P/FCF N/A
P/OCF 23.46
P/B 2.05
P/tB 2.05
EV/EBITDA 22.61
EPS(TTM)1.37
EY3.74%
EPS(NY)1.57
Fwd EY4.3%
FCF(TTM)-4.8
FCFYN/A
OCF(TTM)1.56
OCFY4.26%
SpS1.92
BVpS17.89
TBVpS17.89
PEG (NY)0.35
PEG (5Y)2.36
Graham Number23.48
Profitability
Industry RankSector Rank
ROA 5.12%
ROE 6.53%
ROCE 5.8%
ROIC 4.58%
ROICexc 5.36%
ROICexgc 5.36%
OM 66.5%
PM (TTM) 60.84%
GM 99.38%
FCFM N/A
ROA(3y)1.9%
ROA(5y)3.08%
ROE(3y)2.37%
ROE(5y)4.75%
ROIC(3y)5.24%
ROIC(5y)5.34%
ROICexc(3y)5.66%
ROICexc(5y)5.62%
ROICexgc(3y)5.66%
ROICexgc(5y)5.62%
ROCE(3y)6.63%
ROCE(5y)6.75%
ROICexgc growth 3Y-3.12%
ROICexgc growth 5Y0.18%
ROICexc growth 3Y-3.12%
ROICexc growth 5Y0.18%
OM growth 3Y5.41%
OM growth 5Y3.45%
PM growth 3Y4.22%
PM growth 5Y8.32%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA 2.44
Cap/Depr 1743.27%
Cap/Sales 331.26%
Interest Coverage 8.45
Cash Conversion 95.06%
Profit Quality N/A
Current Ratio 4.05
Quick Ratio 4.05
Altman-Z 4.69
F-Score5
WACC8.58%
ROIC/WACC0.53
Cap/Depr(3y)658.62%
Cap/Depr(5y)503.99%
Cap/Sales(3y)134.69%
Cap/Sales(5y)112.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.28%
EPS 3Y-1.19%
EPS 5Y11.3%
EPS Q2Q%66.67%
EPS Next Y77.17%
EPS Next 2Y38.47%
EPS Next 3Y26.77%
EPS Next 5YN/A
Revenue 1Y (TTM)59.24%
Revenue growth 3Y15.48%
Revenue growth 5Y12.64%
Sales Q2Q%71.16%
Revenue Next Year45.48%
Revenue Next 2Y35.93%
Revenue Next 3Y27.93%
Revenue Next 5YN/A
EBIT growth 1Y62.06%
EBIT growth 3Y21.72%
EBIT growth 5Y16.53%
EBIT Next Year185.44%
EBIT Next 3Y59.41%
EBIT Next 5Y44.17%
FCF growth 1Y-1581.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y138.87%
OCF growth 3Y15.9%
OCF growth 5Y14.1%

CARETRUST REIT INC / CTRE FAQ

What is the fundamental rating for CTRE stock?

ChartMill assigns a fundamental rating of 7 / 10 to CTRE.


What is the valuation status for CTRE stock?

ChartMill assigns a valuation rating of 4 / 10 to CARETRUST REIT INC (CTRE). This can be considered as Fairly Valued.


What is the profitability of CTRE stock?

CARETRUST REIT INC (CTRE) has a profitability rating of 8 / 10.


Can you provide the financial health for CTRE stock?

The financial health rating of CARETRUST REIT INC (CTRE) is 6 / 10.


Can you provide the dividend sustainability for CTRE stock?

The dividend rating of CARETRUST REIT INC (CTRE) is 5 / 10 and the dividend payout ratio is 89.87%.